IL308058A - Molephantin derivatives useful in the treatment of cancer - Google Patents

Molephantin derivatives useful in the treatment of cancer

Info

Publication number
IL308058A
IL308058A IL308058A IL30805823A IL308058A IL 308058 A IL308058 A IL 308058A IL 308058 A IL308058 A IL 308058A IL 30805823 A IL30805823 A IL 30805823A IL 308058 A IL308058 A IL 308058A
Authority
IL
Israel
Prior art keywords
molfentin
history
cancer
useful
treatment
Prior art date
Application number
IL308058A
Other languages
English (en)
Hebrew (he)
Inventor
Hoi Yeung Li
Shunsuke Chiba
Soak Kuan Lai
Cheng Gee Koh
Toon Wah Roland Ong
Original Assignee
Univ Nanyang Tech
Nanyang Herbs Pte Ltd
Hoi Yeung Li
Shunsuke Chiba
Soak Kuan Lai
Cheng Gee Koh
Toon Wah Roland Ong
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nanyang Tech, Nanyang Herbs Pte Ltd, Hoi Yeung Li, Shunsuke Chiba, Soak Kuan Lai, Cheng Gee Koh, Toon Wah Roland Ong filed Critical Univ Nanyang Tech
Publication of IL308058A publication Critical patent/IL308058A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL308058A 2021-04-29 2022-04-27 Molephantin derivatives useful in the treatment of cancer IL308058A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG10202104429U 2021-04-29
PCT/SG2022/050251 WO2022231520A1 (en) 2021-04-29 2022-04-27 Molephantin derivatives useful in the treatment of cancer

Publications (1)

Publication Number Publication Date
IL308058A true IL308058A (en) 2023-12-01

Family

ID=83848883

Family Applications (1)

Application Number Title Priority Date Filing Date
IL308058A IL308058A (en) 2021-04-29 2022-04-27 Molephantin derivatives useful in the treatment of cancer

Country Status (7)

Country Link
US (1) US20250304544A1 (cg-RX-API-DMAC7.html)
EP (1) EP4330241A4 (cg-RX-API-DMAC7.html)
JP (1) JP7897576B2 (cg-RX-API-DMAC7.html)
CN (1) CN117377663A (cg-RX-API-DMAC7.html)
AU (1) AU2022265461A1 (cg-RX-API-DMAC7.html)
IL (1) IL308058A (cg-RX-API-DMAC7.html)
WO (1) WO2022231520A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115919833A (zh) * 2023-01-31 2023-04-07 暨南大学附属第一医院(广州华侨医院) 一种CutC蛋白抑制剂及其应用
AU2024337402A1 (en) * 2023-09-06 2026-03-26 Nanyang Biologics Pte. Ltd. Collective synthesis of phantomolin family through total synthesis of the sesquiterpene lactone molephantin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3418724B2 (ja) * 2000-02-10 2003-06-23 国立医薬品食品衛生研究所長 セスキテルペノイド化合物及びそれを含む医薬
JP2005002050A (ja) * 2003-06-12 2005-01-06 Shiseido Co Ltd 美白剤及びこれを配合した皮膚外用剤
CN102000072A (zh) * 2009-09-01 2011-04-06 奇复康药物研发(苏州)有限公司 偶联有一氧化氮供体的抗肿瘤天然药物及其医药用途
CN103732586B (zh) * 2011-04-07 2016-02-03 南洋理工大学 作为抗癌剂的乙酰基丹参酮iia(ata)
US11634400B2 (en) 2017-08-19 2023-04-25 University Of Rochester Micheliolide derivatives, methods for their preparation and their use as anticancer and antiinflammatory agents
CN111153910B (zh) * 2020-01-09 2021-07-30 沈阳药科大学 地胆草种内酯衍生物及其制备方法和用途

Also Published As

Publication number Publication date
US20250304544A1 (en) 2025-10-02
JP7897576B2 (ja) 2026-07-30
AU2022265461A1 (en) 2023-11-16
JP2024517443A (ja) 2024-04-22
CN117377663A (zh) 2024-01-09
EP4330241A1 (en) 2024-03-06
WO2022231520A1 (en) 2022-11-03
EP4330241A4 (en) 2025-03-19

Similar Documents

Publication Publication Date Title
IL309232A (en) Urea derivatives which can be used to treat cancer
IL260400B (en) Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies
IL286079A (en) Imidazolonylquinoline compounds and therapeutic uses thereof
JP1789691S (ja) 皮膚治療機器
IL270511A (en) Combination therapies using niraparib and pembrolizumab for treating cancer
HUE063145T2 (hu) Deuterált vegyületek rákos megbetegedések kezelésében történõ alkalmazásra
PL3429571T3 (pl) Kombinacje inhibitorów lsd1 do zastosowania w leczeniu chorób nowotworowych
EP4199869A4 (en) ULTRASOUND TREATMENT OF VITREOUS OPACITIES
IL287904A (en) Combination treatment of arthritic disease
EP3471717A4 (en) TREATMENT OF PLATE CELL CARCINOMAS WITH ERK INHIBITORS
EP4149453A4 (en) COMBINATION TREATMENT OF LIVER DISEASES
EP4493175A4 (en) MIRDAMETINIB TREATMENT
EP4003299A4 (en) Treatment of skin disorders with topical tapinarof-egfr inhibitor compositions
EP4393493A4 (en) PARP INHIBITOR-RESISTANT PATIENT TREATED WITH TH-302
EP3735209A4 (en) TREATMENT OF THE PROGRESSION OF MYOPOIA
EP4301356A4 (en) Treatment of breast cancer with amcenestrant and palbociclib
IL282273A (en) Urea derivatives for treating and/or preventing cancer
IL289371A (en) Methylthioninium for use in the treatment of synaptopathies
EP4021858A4 (en) TREATMENT OF AZOLES
EP4355238A4 (en) ELECTROPORATION TREATMENT
IL280395A (en) Tetrahydroquinolino derivatives for the treatment of metastatic and chemoresistant cancers
IL291424A (en) Use of dkk-1 inhibitors for treating cancer
PL3630112T3 (pl) Kombinacja regorafenibu i niwolumabu w leczeniu nowotworu
IL325421A (en) Combinational treatment
IL272194A (en) Multispecific antibodies for use in treating diseases